PRADEEP MANUDHANE: Open Payments
NPI 1316991599 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322,833 in 435 payments from 10 companies in 2025. Trend: 2023 $271,055 · 2024 $227,056 · 2025 $322,833
Speaker / faculty: $242,510Honoraria: $29,975Consulting: $25,260Travel & lodging: $17,823Food & beverage: $7,264
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 106 | $90,386 |
| E.R. Squibb & Sons, L.L.C. | 80 | $55,781 |
| Teva Pharmaceuticals USA, Inc. | 61 | $53,026 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 50 | $45,403 |
| Axsome Therapeutics, Inc. | 41 | $32,055 |
| ABBVIE INC. | 37 | $17,064 |
| Alkermes, Inc. | 32 | $15,297 |
| Otsuka America Pharmaceutical, Inc. | 19 | $13,628 |
| Neurocrine BioSciences, Inc. | 8 | $170 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
Products named: FANAPT, COBENFY, CAPLYTA, Auvelity, AUSTEDO XR, UZEDY, VRAYLAR, LYBALVI.
Industry payments across OH — which companies pay providers there.
